Sarepta Therapeutics | SRPT - 资产

股票价格
22.38
每天变化
-0.70 -3.03%
每月一次
26.87%
每年
-59.78%
Q2 预测
22.53


金融业
股票价格
USD
资产
USD 3.35B
现金及等价物
USD 801.28M
销售成本
USD 399.39M
流动资产
USD 2.54B
流动负债
USD 1.1B
债务
USD 1.25B
EBIT
USD -410.08M
EBITDA
USD -168.03M
员工
1.37K
EPS每股收益
USD -3.58
股本和储备
USD 1.14B
销售毛利
USD 43.55M
债务利息支出
USD 7.56M
利息收入
USD 8.38M
贷款资金
USD 828.97M
市值
USD 2.17B
净收入
USD -412.23M
营业费用
USD 853.02M
营业利润
USD -410.08M
普通股股本
USD 104.96M
PE价格收益
27.27
税前利润
USD -407.68M
销售收入
USD 442.9M
销售和管理费用
USD 105.38M
股票
USD 914.74M
贸易债权人
USD 280.84M
应收帐款人
USD 398.23M


资产 更改 日
Acadia Pharmaceuticals USD 1.56B 233.42M 2025-12
Agios Pharmaceuticals USD 1.3B 88.48M 2025-12
Alnylam Pharmaceuticals USD 4.97B 114.67M 2025-12
Amgen USD 90.59B 445M 2025-12
BioCryst Pharmaceuticals USD 514.16M 67.73M 2025-12
Biogen USD 29.44B 232M 2025-12
BioMarin Pharmaceutical USD 7.59B 20.85M 2025-12
Capricor Therapeutics USD 355.95M 229.51M 2025-12
Daiichi Sankyo JPY 3.82T 252.52B 2025-12
Eli Lilly USD 112.48B 2.46B 2025-12
Esperion Therapeutics USD 465.89M 101.87M 2025-12
Gilead Sciences USD 59.02B 490M 2025-12
Incyte USD 6.96B 627.62M 2025-12
Insmed USD 2.26B 96.18M 2025-12
Ionis Pharmaceuticals USD 3.52B 490.91M 2025-12
Moderna USD 12.34B 203M 2025-12
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Neurocrine Biosciences USD 4.63B 365.8M 2025-12
Novavax USD 1.18B 3.38M 2025-12
Pfizer USD 208.73B 2.64B 2025-09
PTC Therapeutics USD 2.9B 255.07M 2025-12
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sanofi EUR 126.81B 2.99B 2025-12
Sarepta Therapeutics USD 3.35B 143.73M 2025-12
Tectonic Therapeutic USD 261.04M 15.96M 2025-12
Ultragenyx Pharmaceutical USD 1.53B 341.56M 2025-12
Vertex Pharmaceuticals USD 25.64B 780.7M 2025-12